Cardiovascular and metabolic risks associated with PCOS

Internal and Emergency Medicine

Volumn 8, Issue SUPPL. 1, 2013, Pages 61-64

  Cobin, Rhoda H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Diabetes; PCOS

Indexed keywords

EID: 84875638162     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-0924-z     Document Type: Review

References (19)

1. Korhonen S (2001) Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol 184: 289-296.
2. Korhonen S (2003) The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil Steril 79: 1327-1334.
3. Asagami T, Holmes TH, Reaven G (2008) Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation. Metabolism 57(10): 1355-1360.
4. Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C (2008) The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Clin Endocrinol (Oxf) 69: 52-60.
5. Guastella E, Longo RA, Carmina E (2010) Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril 94: 2197-2201.
6. Coviello AD, Legro RS, Dunaif A (2006) Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91: 492-497.
7. Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalance and predictors of type 2 diabetes and impaired glucose tolerance in PCOS: a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 84: 165-169.
8. Moran LJ, Misso ML, Wild RA, Norman RJ (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycistic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16: 347-363.
9. Wild RA, Rizzo M, Clifton S, Carmina E (2011) Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95: 1073-1079.
10. Sidhwani S, Scoccia B, Sunghay S, Stephens-Archer CN, Mazzone T, Sam S. (2011) PCOS is Associated with Atherogenic Changes in Lipoprotein Particle Number and size independent of body weight. Clin Endocrinol (Oxf) 2011 Clin Endocrinol (Oxf). 2011 Feb 15. doi: 10. 1111/j. 1365-2265. 2011. 04015. x.
11. Toulis KA, Goulis KA, Goulis DG, Mintziori G, Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S, Poulasouchidou M, Tzellos TG, Makedos A, Chourdakis M, Tarlatzis BC (2011) Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update 17: 741-760.
12. Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F (2011) Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril 95: 1048-1058.
13. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF 2nd, Fitzpatrick LA (2003) Prevalence and predictors of coronary artery calcification in women with polycistic ovary syndrome. J Clin Endocrinol Metab 88: 2562-2568.
14. Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF (2007) Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum Reprod 22: 3197-3203.
15. de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM (2011) PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 17: 495-500.
16. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD (2008) Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93: 1276-1284.
17. Raval AD, Hunter T, Stuckey B, Hart RJ (2011) Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst Rev (10): CD008565. doi: 10. 1002/14651858. CD008565. pub2.
18. Puurumen J, Piltonen T, Morin-Papunen L, Perheentupa A, Jarvela I, Ruokonen A, Tapaneinen JS (2011) Unfavorable hormonal, metabolic and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab 96(6): 1827-1834.
19. Wild RA et al (2010) CHD Events in the WHI hormone therapy trials: does presence or absence of metabolic syndrome at baseline modify the risk? Abstract S-3 21st annual meeting of NAMS. Menopause 17: 1216.